Literature DB >> 6286937

Inhibition of respiratory neural discharges by clonidine and 5-hydroxytryptophan.

D R McCrimmon, P M Lalley.   

Abstract

Activation of receptors for norepinephrine or serotonin in the central nervous system by i.v. injection of clonidine (10-50 micrograms/kg) or 5-hydroxytryptophan (20-40 mg/kg) inhibits phrenic neural discharges in anesthetized, artificially ventilated cats. Clonidine induces a rapid and complete inhibition of phrenic nerve activity which lasts for 1 to 3.2 hr. The inhibition is prevented by prior administration of phenoxybenzamine (10 mg/kg) or tolazoline (3 mg/kg). 5-Hydroxytryptophan, injected after inhibition of peripheral amino acid decarboxylase (carbidopa, 30-50 mg/kg), elicits a gradual but complete inhibition of phrenic nerve discharges which persists for 1 to 10 hr and is unaltered by alpha or beta adrenoceptor blocking agents. The inhibitions produced by clonidine and 5-hydroxytryptophan are overcome transiently during hypercapnia. Stimulation of carotid body chemoreceptors by i.a. injections of lobeline, doxapram or 0.015 N HCl in saline also briefly reinstates phrenic nerve discharges after inhibition by clonidine. Inhibition is also overcome during electrical stimulation of the carotid sinus nerve.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286937

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Mediation of serotonin-induced hyperventilation via 5-HT3-receptor in European eel Anguilla anguilla.

Authors:  J J Janvier; M Peyraud-Waïtzenegger; P Soulier
Journal:  J Comp Physiol B       Date:  1996       Impact factor: 2.200

2.  5-HT2 receptor-controlled modulation of medullary respiratory neurones in the cat.

Authors:  P M Lalley; A M Bischoff; S W Schwarzacher; D W Richter
Journal:  J Physiol       Date:  1995-09-15       Impact factor: 5.182

3.  5-HT-1A receptor-mediated modulation of medullary expiratory neurones in the cat.

Authors:  P M Lalley; A M Bischoff; D W Richter
Journal:  J Physiol       Date:  1994-04-01       Impact factor: 5.182

4.  Chronic serotonin-norepinephrine reuptake transporter inhibition modifies basal respiratory output in adult mouse in vitro and in vivo.

Authors:  Kelly A Warren; Irene C Solomon
Journal:  Respir Physiol Neurobiol       Date:  2012-07-31       Impact factor: 1.931

Review 5.  The role of serotonin in respiratory function and dysfunction.

Authors:  Gérard Hilaire; Nicolas Voituron; Clément Menuet; Ronaldo M Ichiyama; Hari H Subramanian; Mathias Dutschmann
Journal:  Respir Physiol Neurobiol       Date:  2010-08-27       Impact factor: 1.931

6.  Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trials.

Authors:  John A Zebala; Shawn L Searle; Lynn R Webster; Matt S Johnson; Aaron D Schuler; Dean Y Maeda; Stuart J Kahn
Journal:  J Pain       Date:  2019-04-18       Impact factor: 5.820

7.  Serotoninergic and non-serotoninergic responses of phrenic motoneurones to raphe stimulation in the cat.

Authors:  P M Lalley
Journal:  J Physiol       Date:  1986-11       Impact factor: 5.182

8.  Breathing and temperature control disrupted by morphine and stabilized by clonidine in neonatal rats.

Authors:  Kalpashri Kesavan; Tarrah Ezell; Alexis Bierman; Ana Rita Nunes; Frances J Northington; Clarke G Tankersley; Estelle B Gauda
Journal:  Respir Physiol Neurobiol       Date:  2014-07-05       Impact factor: 1.931

9.  A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

Authors:  P Ernsberger; M A Haxhiu; L M Graff; L A Collins; I Dreshaj; D L Grove; M E Graves; S G Schäfer; M O Christen
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

10.  Suppression of the cough reflex by α 2-adrenergic receptor agonists in the rabbit.

Authors:  Elenia Cinelli; Fulvia Bongianni; Tito Pantaleo; Donatella Mutolo
Journal:  Physiol Rep       Date:  2013-11-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.